Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1975 1
1978 1
1979 1
1980 1
1982 1
1984 3
1985 1
1997 1
1998 1
2000 2
2002 1
2003 3
2006 1
2007 1
2009 1
2010 3
2011 2
2012 8
2013 4
2014 7
2015 12
2016 13
2017 8
2018 14
2019 18
2020 22
2021 22
2022 28
2023 30
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Results by year

Filters applied: . Clear all
Page 1
Effects of increasing cannabis potency on adolescent health.
Wilson J, Freeman TP, Mackie CJ. Wilson J, et al. Among authors: freeman tp. Lancet Child Adolesc Health. 2019 Feb;3(2):121-128. doi: 10.1016/S2352-4642(18)30342-0. Epub 2018 Dec 18. Lancet Child Adolesc Health. 2019. PMID: 30573419 Review.
Keep off the grass? Cannabis, cognition and addiction.
Curran HV, Freeman TP, Mokrysz C, Lewis DA, Morgan CJ, Parsons LH. Curran HV, et al. Among authors: freeman tp. Nat Rev Neurosci. 2016 May;17(5):293-306. doi: 10.1038/nrn.2016.28. Epub 2016 Apr 7. Nat Rev Neurosci. 2016. PMID: 27052382 Free article. Review.
Benefits and risks of cannabinoids.
Freeman TP, Hall W. Freeman TP, et al. BMJ. 2023 Sep 18;382:2113. doi: 10.1136/bmj.p2113. BMJ. 2023. PMID: 37722728 No abstract available.
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM; EU-GEI WP2 Group. Di Forti M, et al. Among authors: freeman tp. Lancet Psychiatry. 2019 May;6(5):427-436. doi: 10.1016/S2215-0366(19)30048-3. Epub 2019 Mar 19. Lancet Psychiatry. 2019. PMID: 30902669 Free PMC article.
Can we make cannabis safer?
Englund A, Freeman TP, Murray RM, McGuire P. Englund A, et al. Among authors: freeman tp. Lancet Psychiatry. 2017 Aug;4(8):643-648. doi: 10.1016/S2215-0366(17)30075-5. Epub 2017 Mar 2. Lancet Psychiatry. 2017. PMID: 28259650 Review.
Restrictions on drugs with medical value: Moving beyond stalemate.
Freeman TP, Mehta MA, Neill JC, Nutt DJ, Tunbridge EM, Young AH. Freeman TP, et al. J Psychopharmacol. 2018 Oct;32(10):1053-1055. doi: 10.1177/0269881118798609. Epub 2018 Oct 2. J Psychopharmacol. 2018. PMID: 30278146 No abstract available.
The neuropsychopharmacology of cannabis: A review of human imaging studies.
Bloomfield MAP, Hindocha C, Green SF, Wall MB, Lees R, Petrilli K, Costello H, Ogunbiyi MO, Bossong MG, Freeman TP. Bloomfield MAP, et al. Among authors: freeman tp. Pharmacol Ther. 2019 Mar;195:132-161. doi: 10.1016/j.pharmthera.2018.10.006. Epub 2018 Oct 19. Pharmacol Ther. 2019. PMID: 30347211 Free PMC article. Review.
181 results